United States: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Health-e Law Episode 26, Part 2 | AI Adoption In Healthcare: Opportunities, Risks And The Future Of Care Delivery (Podcast)

Welcome to Health-e Law, Sheppard’s podcast exploring the fascinating health tech topics and trends of the day. In the second part of this two-part episode, Cora Han, Chief Health Data Officer for University...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA In Flux — June 2026 Newsletter

FDA leadership has undergone unprecedented transformation following widespread departures in 2025-2026, creating uncertainty about the future of Commissioner...

United States Healthcare

M

Mintz

Community & Commitment Report

Highlights of women attorneys leading impactful matters for clients, from a state Supreme Court climate ruling to a False Claims Act resolution for a national health care network

United States Healthcare

M

Mintz

FDA In Flux - June 2026

Welcome to FDA in Flux – A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

United States Healthcare

M

Mintz

HHS-OIG Issues Unfavorable Advisory Opinion On Orthopedic Device Manufacturer's Proposed Royalty Payment Arrangement

United States Healthcare

BT

Barnes & Thornburg LLP

Smoke Is Not Fire: Fourth Circuit Rejects Stark And AKS Theories Built On Ordinary Business Practices And Conclusory Allegations

United States Healthcare

BB

Bass, Berry & Sims

Alvotech’s BLA For Vedolizumab Biosimilar First To Be Accepted By FDA

United States Healthcare

GP

Goodwin Procter LLP

OIG Reiterates: FAQs Are Facts When It Comes To Stark And AKS Compliance

United States Healthcare

DS

Dinsmore & Shohl

Incyte To Acquire Vega Therapeutics, Adding Phase 3 Bleeding Disorder Asset

United States Healthcare

GP

Goodwin Procter LLP

Investing In Integrated Women’s Health Platforms: Navigating Regulatory And Operational Complexity

United States Healthcare

KM

Katten Muchin Rosenman LLP

FDA Approves Lupin’s Ranibizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

National Security Controls And The Life Sciences Sector: BIOSECURE Act, Section 1260H, And COINS Act Developments

United States Healthcare

AP

Arnold & Porter

DOJ, CMS Announce New Data-Sharing Programs In Indiana And Ohio, Looks To Ramp Up Fraud Enforcement In The Midwest

United States Healthcare

BT

Barnes & Thornburg LLP

FDA Updates 8-Year-Old Payor Communications Guidance

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Tennessee Limits Non-Compete Agreements With Lower Compensated Employees While Presuming That Restrictive Covenants Of Up To Two Years Are Reasonable In Duration

United States Employment

CL

Carter Ledyard & Milburn

AI Notetakers: Productivity Tool Or Emerging Legal Risk?

United States Technology

MB

Mayer Brown

Ambiguity Of Measurement Conditions For Relevant Chemical Property Leads To Federal Circuit Affirming Noninfringement Of Epoprostenol Patents

United States IP

DM

Duane Morris LLP

Federal Court Vacates $100K H-1B Payment Requirement

United States Immigration

FL

Fennemore

From Access To Advancement: Mentorship And Sponsorship For Women Lawyers In Idaho

United States Employment

FL

Fennemore

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

The Price Isn’t Right: Emerging Patchwork Of State Surveillance Pricing Bans Creates Compliance Complications For Businesses

On June 4, 2026, the New York legislature passed the One Fair Price Act, which, if signed into law by Governor Kathy Hochul, would prohibit businesses from using surveillance...

United States Anti-trust

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA In Flux — June 2026 Newsletter

FDA leadership has undergone unprecedented transformation following widespread departures in 2025-2026, creating uncertainty about the future of Commissioner...

United States Healthcare

M

Mintz

SPCs To Keep The CJEU Busy: Four Referrals To Watch

Four pending cases before the Court of Justice of the European Union are set to clarify critical aspects of Supplementary Protection Certificate (SPC) law, addressing questions about manufacturing waivers, the definition of medicinal products, and what constitutes a "first" marketing authorisation. These referrals from Danish, German, and Czech courts involve major pharmaceutical companies and could significantly impact SPC strategy across EU member states.

United States IP

JA

J A Kemp LLP

FDA In Flux - June 2026

United States Healthcare

M

Mintz

Evolving And Modernizing Pharmaceutical IP Portfolio Planning

United States IP

BT

Barnes & Thornburg LLP

The Fillet, The "Whole" Fillet, And Nothing But The Fillet?

United States Consumer

GA

Global Advertising Lawyers Alliance (GALA)

Alvotech’s BLA For Vedolizumab Biosimilar First To Be Accepted By FDA

United States Healthcare

GP

Goodwin Procter LLP

The Motion To Stay DEA’s Schedule III Rule: Strong Enough To Stick?

United States Government

HS

Harris Sliwoski

Supreme Court Clarifies Induced Infringement Standard And Reinforces Skinny-Label Protection For Generic Drug Manufacturers

United States IP

LD

Lerner David

See more

Life Sciences, Biotechnology & Nanotechnology

The Price Isn’t Right: Emerging Patchwork Of State Surveillance Pricing Bans Creates Compliance Complications For Businesses

On June 4, 2026, the New York legislature passed the One Fair Price Act, which, if signed into law by Governor Kathy Hochul, would prohibit businesses from using surveillance...

United States Anti-trust

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA In Flux — June 2026 Newsletter

FDA leadership has undergone unprecedented transformation following widespread departures in 2025-2026, creating uncertainty about the future of Commissioner...

United States Healthcare

M

Mintz

Community & Commitment Report

Highlights of women attorneys leading impactful matters for clients, from a state Supreme Court climate ruling to a False Claims Act resolution for a national health care network

United States Healthcare

M

Mintz

Alvotech’s BLA For Vedolizumab Biosimilar First To Be Accepted By FDA

United States Healthcare

GP

Goodwin Procter LLP

Incyte To Acquire Vega Therapeutics, Adding Phase 3 Bleeding Disorder Asset

United States Healthcare

GP

Goodwin Procter LLP

FDA Approves Lupin’s Ranibizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

National Security Controls And The Life Sciences Sector: BIOSECURE Act, Section 1260H, And COINS Act Developments

United States Healthcare

AP

Arnold & Porter

Comparing EPC Article 53(a) And US Patent Law In Gene Editing Ethics

United States IP

PC

Potter Clarkson

FDA Proposes Revised Payor Communications Draft Guidance To Formally Include Devices And Reflect New Statutory Safe Harbor While Balancing Substantial Government Interests

United States Healthcare

AP

Arnold & Porter

See more

Healthcare

Health-e Law Episode 26, Part 2 | AI Adoption In Healthcare: Opportunities, Risks And The Future Of Care Delivery (Podcast)

Welcome to Health-e Law, Sheppard’s podcast exploring the fascinating health tech topics and trends of the day. In the second part of this two-part episode, Cora Han, Chief Health Data Officer for University...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

The Price Isn’t Right: Emerging Patchwork Of State Surveillance Pricing Bans Creates Compliance Complications For Businesses

On June 4, 2026, the New York legislature passed the One Fair Price Act, which, if signed into law by Governor Kathy Hochul, would prohibit businesses from using surveillance...

United States Anti-trust

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA In Flux — June 2026 Newsletter

FDA leadership has undergone unprecedented transformation following widespread departures in 2025-2026, creating uncertainty about the future of Commissioner...

United States Healthcare

M

Mintz

Community & Commitment Report

United States Healthcare

M

Mintz

FDA In Flux - June 2026

United States Healthcare

M

Mintz

HHS-OIG Issues Unfavorable Advisory Opinion On Orthopedic Device Manufacturer's Proposed Royalty Payment Arrangement

United States Healthcare

BT

Barnes & Thornburg LLP

Smoke Is Not Fire: Fourth Circuit Rejects Stark And AKS Theories Built On Ordinary Business Practices And Conclusory Allegations

United States Healthcare

BB

Bass, Berry & Sims

Alvotech’s BLA For Vedolizumab Biosimilar First To Be Accepted By FDA

United States Healthcare

GP

Goodwin Procter LLP

OIG Reiterates: FAQs Are Facts When It Comes To Stark And AKS Compliance

United States Healthcare

DS

Dinsmore & Shohl

See more

Latest Videos

See more

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

The Business Of Breakthroughs: Mayo Clinic On Innovation And The Future Of Care (Video)

AM

Alvarez & Marsal

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More